Martin Taphoorn MD, PhD, is a neurologist and professor in neuro-oncology at Leiden University Medical Center and Haaglanden Medical Center. Martin co-leads Work Package 5.
Martin Taphoorn obtained his MD at Leiden University and subsequently specialized in Clinical Neurology in Amsterdam VU Medical Center, where he also wrote his PhD thesis “Treatment of primary and metastatic brain tumours; beneficial and adverse effects”. He further specialised in Clinical neuro-oncology at University Medical Center Utrecht and during a sabbatical leave he visited MD Anderson Cancer Center Houston Texas (Dr. Levin) and Memorial Sloan-Kettering Cancer Center New York (Dr. DeAngelis).
From 2003 he is neurologist/neuro-oncologist at Haaglanden Medical Center The Hague, where he was head of the residency program of Neurology, and at Leiden University Medical Center. He obtained a Professorship in Neuro-Oncology at the Free University in Amsterdam and later on at Leiden University. From 2009-2011 he was president of the Netherlands Society of Neurology.
He is actively involved in both the EORTC Brain Tumor Group and EORTC Quality of Life Group, as well as in EANO and SNO and has authored over 250 peer-reviewed articles. His research activities are focused on clinical outcomes in neuro-oncology (cognition, epilepsy, imaging, health-related quality of life, end of life).